Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Despite the popularity of urethrotomy for treating urethral strictures in men, the success rate is less than 10% initially and may drop to…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate (MgSO4) does not benefit patients with acute aneurysmal subarachnoid hemorrhage, according to results of a phase III trial. In the…
NEW YORK (Reuters Health) – Although promethazine and metoclopramide have similar antiemetic effects in hyperemesis gravidarum, metoclopramide has fewer side effects, according to a study published online April…
NEW YORK (Reuters Health) – Patients with left ventricular (LV) dysfunction should receive human atrial natriuretic peptide (hANP) infusions during coronary artery bypass graft (CABG) surgery, Japanese researchers…
NEW YORK (Reuters Health) – The nonselective beta-blocker carvedilol and the beta-1-selective beta-blockers metoprolol succinate and bisoprolol have significantly different treatment effects in patients with chronic heart failure…
NEW YORK (Reuters Health) – The “dramatic benefits” of probiotic supplements for reducing death and necrotizing enterocolitis (NEC) in very low birth weight (VLBW) preterm neonates have been…
NEW YORK (Reuters Health) – Positron emission tomography (PET) of the liver is extremely unreliable in patients who’ve just had chemotherapy for colorectal cancer metastases, because the false-negative…
NEW YORK (Reuters Health) – During a no-scalpel vasectomy, lidocaine given via a short fine needle provides excellent anesthesia, Canadian and US researchers report in the May issue…
NEW YORK (Reuters Health) – Clopidogrel reloading does not benefit patients undergoing percutaneous coronary intervention (PCI) who are already on chronic clopidogrel therapy, Italian researchers reported online April…
NEW YORK (Reuters Health) – In older patients with normal lipids but high C-reactive protein, primary prevention therapy with rosuvastatin (Crestor) does not lower mortality, but it does…
